The Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at a high P/E of 43.80 despite negative forward P/E and inconsistent earnings, suggesting overvaluation relative to near-term profitability. The intrinsic value estimate of $1.05 is significantly below the current price of $6.57, indicating a substantial valuation gap. Despite modest revenue growth of 3.2% YoY, the company exhibits weak profitability (0.95% net margin) and deteriorating earnings trends, with a recent -9.5% Q/Q EPS decline. The 5-year price drop of 91% underscores long-term underperformance.